Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

NCT01022060 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT01022060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01022060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
February 28, 2010
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent calcic urolithiasis